Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Ayman Oweida
Affiliation
Universite de Sherbrooke
ORCID
Career Start Year
2004
Papers
39
H Index
17
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
34264178
Reconciling two opposing effects of radiation therapy: stimulation of cancer cell invasion and activation of anti-cancer immunity.
Int J Radiat Biol
2023
37124531
A novel preclinical model of craniospinal irradiation in pediatric diffuse midline glioma demonstrates decreased metastatic disease.
Front Oncol
2023
37112730
Toll-Like Receptors and the Response to Radiotherapy in Solid Tumors: Challenges and Opportunities.
Vaccines (Basel)
2023
36326893
Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy.
Cancer Immunol Immunother
2023
34559306
Loss of cancer cell STAT1 improves response to radiation therapy and promotes T cell activation in head and neck squamous cell carcinoma.
Cancer Immunol Immunother
2022
34793974
Dichotomous effects of cellular expression of STAT3 on tumor growth of HNSCC.
Mol Ther
2022
33097963
Response to radiotherapy in pancreatic ductal adenocarcinoma is enhanced by inhibition of myeloid-derived suppressor cells using STAT3 anti-sense oligonucleotide.
Cancer Immunol Immunother
2021
33883256
Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis.
J Immunother Cancer
2021
33485341
Role of epidermal growth factor receptor inhibitor-induced interferon pathway signaling in the head and neck squamous cell carcinoma therapeutic response.
J Transl Med
2021
33526513
Induction of ADAM10 by Radiation Therapy Drives Fibrosis, Resistance, and Epithelial-to-Mesenchyal Transition in Pancreatic Cancer.
Cancer Res
2021
30977524
Epidemiology and treatment trends for primary tracheal squamous cell carcinoma.
Laryngoscope
2020
32139402
PARP Inhibition Enhances Radiotherapy of SMAD4-Deficient Human Head and Neck Squamous Cell Carcinomas in Experimental Models.
Clin Cancer Res
2020
32567728
The effects of ephrinB2 signaling on proliferation and invasion in glioblastoma multiforme.
Mol Carcinog
2020
30403264
Effects of ranibizumab and amfenac on the functional abilities and radiosensitivity of uveal melanoma cells.
Arq Bras Oftalmol
2019
31276586
Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymoma.
Neuro Oncol
2019
30894369
Inhibition of EphB4-Ephrin-B2 Signaling Reprograms the Tumor Immune Microenvironment in Head and Neck Cancers.
Cancer Res
2019
30863843
STAT3 Modulation of Regulatory T Cells in Response to Radiation Therapy in Head and Neck Cancer.
J Natl Cancer Inst
2019
30944125
Pancreatic Tumor Microenvironment Modulation by EphB4-ephrinB2 Inhibition and Radiation Combination.
Clin Cancer Res
2019
30766539
Overcoming Resistance to Combination Radiation-Immunotherapy: A Focus on Contributing Pathways Within the Tumor Microenvironment.
Front Immunol
2019
31058896
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment.
J Vis Exp
2019
29774792
Hypofractionated Radiotherapy Is Superior to Conventional Fractionation in an Orthotopic Model of Anaplastic Thyroid Cancer.
Thyroid
2018
29970482
Role of EphB3 Receptor in Mediating Head and Neck Tumor Growth, Cell Migration, and Response to PI3K Inhibitor.
Mol Cancer Ther
2018
30098782
Nomogram for preoperative prediction of nodal extracapsular extension or positive surgical margins in oropharyngeal squamous cell carcinoma.
Oral Oncol
2018
30042205
Resistance to Radiotherapy and PD-L1 Blockade Is Mediated by TIM-3 Upregulation and Regulatory T-Cell Infiltration.
Clin Cancer Res
2018
29848571
Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers.
Clin Cancer Res
2018
30084837
Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer.
Clin Cancer Res
2018
27649287
Ephrin-B2 overexpression predicts for poor prognosis and response to therapy in solid tumors.
Mol Carcinog
2017
28360821
Combined EphB2 receptor knockdown with radiation decreases cell viability and invasion in medulloblastoma.
Cancer Cell Int
2017
28374095
Benefit of re-operation and salvage therapies for recurrent glioblastoma multiforme: results from a single institution.
J Neurooncol
2017
29416719
Response to stereotactic ablative radiotherapy in a novel orthotopic model of non-small cell lung cancer.
Oncotarget
2017
29153603
Impact of immunotherapy among patients with melanoma brain metastases managed with radiotherapy.
J Neuroimmunol
2017
29123967
Ionizing radiation sensitizes tumors to PD-L1 immune checkpoint blockade in orthotopic murine head and neck squamous cell carcinoma.
Oncoimmunology
2017
28764811
Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy.
J Transl Med
2017
27727461
A comparison of overall survival for patients with T4 larynx cancer treated with surgical versus organ-preservation approaches: A National Cancer Data Base analysis.
Cancer
2017
27109097
Ablative versus fractionated radiation therapy: a controversial role in cancer invasion and metastasis.
Oncogene
2016
27941840
Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell Carcinomas.
Sci Rep
2016
27096542
Differential response to ablative ionizing radiation in genetically distinct non-small cell lung cancer cells.
Cancer Biol Ther
2016
17659552
Iron-oxide labeling of hematogenous macrophages in a model of experimental autoimmune encephalomyelitis and the contribution to signal loss in fast imaging employing steady state acquisition (FIESTA) images.
J Magn Reson Imaging
2007
15296673
Cellular imaging at 1.5 T: detecting cells in neuroinflammation using active labeling with superparamagnetic iron oxide.
Mol Imaging
2004
1 - 39 of 39
Column Actions
Search
Recommended Authors
Melvin L K Chua
National Cancer Centre Singapore
Career Start Year
2011
Number of shared co-authors
1
Nikhil T Sebastian
Emory University
Career Start Year
2011
Number of shared co-authors
0
Joseph Sia
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year
2011
Number of shared co-authors
0
Anusha Kalbasi
Stanford Cancer Institute, Stanford School of Medicine
Career Start Year
2010
Number of shared co-authors
0
Robert Saddawi-Konefka
Moores Cancer Center, University of California San Diego
Career Start Year
2010
Number of shared co-authors
1
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year
2009
Number of shared co-authors
1
Emmanouil Fokas
Universityhospital Frankfurt
Career Start Year
2007
Number of shared co-authors
0
Julie E Bauman
George Washington University
Career Start Year
2007
Number of shared co-authors
1
Aruz Mesci
Juravinski Cancer Centre
Career Start Year
2006
Number of shared co-authors
0
Sophia Bornstein
Cornell University
Career Start Year
2005
Number of shared co-authors
2
Nadeem Riaz
Memorial Sloan Kettering Cancer Center
Career Start Year
2004
Number of shared co-authors
3
Philip Wong
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2002
Number of shared co-authors
0
Ezra E W Cohen
university of california san diego Health System
Career Start Year
2001
Number of shared co-authors
2
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year
2001
Number of shared co-authors
2
Christopher D Willey
University of Alabama at Birmingham
Career Start Year
2000
Number of shared co-authors
0
Chiaojung Jillian Tsai
Memorial Sloan Kettering Cancer Center
Career Start Year
2000
Number of shared co-authors
0
Eddy S Yang
University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center
Career Start Year
1999
Number of shared co-authors
0
Richard J Wong
Memorial Sloan Kettering Cancer Center
Career Start Year
1998
Number of shared co-authors
0
Puneeth Iyengar
UT Southwestern Medical Center, Center for Human Nutrition
Career Start Year
1996
Number of shared co-authors
0
Stanley K Liu
Odette Cancer Centre, University of Toronto
Career Start Year
1995
Number of shared co-authors
0
Stephen Y Lai
The University of Texas MD Anderson Cancer Center
Career Start Year
1995
Number of shared co-authors
1
Johan Bussink
Radboud University, Nijmegen Medical Centre
Career Start Year
1995
Number of shared co-authors
0
Kevin Camphausen
National Cancer Institute
Career Start Year
1994
Number of shared co-authors
0
Melania Pintilie
Princess Margaret Cancer Centre, University Health Network
Career Start Year
1993
Number of shared co-authors
0
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year
1988
Number of shared co-authors
2
Ravindra Uppaluri
Brigham and Women's Hospital
Career Start Year
1988
Number of shared co-authors
1
Jeffrey N Myers
The University of Texas MD Anderson Cancer Center
Career Start Year
1988
Number of shared co-authors
2
Silvia C Formenti
Weill Cornell Medical College
Career Start Year
1986
Number of shared co-authors
1
Sandra Demaria
Weill Cornell Medical College
Career Start Year
1985
Number of shared co-authors
1
Carter Van Waes
National Institute of Deafness and Other Communication Disorders
Career Start Year
1984
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Sana D Karam
University of Colorado School of Medicine
Co-authored papers
29
Shilpa Bhatia
University of Colorado Denver at Anschutz Medical Campus
Co-authored papers
19
Benjamin Van Court
University of Colorado
Co-authored papers
15
Laurel B Darragh
University of Colorado Denver at Anschutz Medical Campus
Co-authored papers
11
Andy Phan
University of Colorado Anschutz Medical Campus
Co-authored papers
10
Adam C Mueller
Sidney Kimmel Cancer Center at Thomas Jefferson University
Co-authored papers
7
Antonio Jimeno
University of Colorado School of Medicine
Co-authored papers
5
Rajeev Vibhakar
Center for Cancer and Blood Disorders, Children's Hospital Colorado.
Co-authored papers
4
Thomas E Bickett
University of Colorado
Co-authored papers
4
Kirk C Hansen
University of Colorado Anschutz Medical Campus
Co-authored papers
3
Wells A Messersmith
University of Colorado Anschutz Medical Campus
Co-authored papers
3
Richard D Schulick
University of Colorado School of Medicine
Co-authored papers
3
Jason Williams
University of Colorado Denver
Co-authored papers
3
Kimberly R Jordan
University of Colorado Anschutz Medical Campus
Co-authored papers
3
Karyn A Goodman
Mount Sinai Hospital
Co-authored papers
3
Marco Del Chiaro
University of Colorado
Co-authored papers
2
Sujatha Venkataraman
Co-authored papers
2
Andrew Goodspeed
University of Colorado Denver | Anschutz Medical Campus
Co-authored papers
2
Elena B Pasquale
Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers
2
Stephen B Keysar
University of Colorado Denver
Co-authored papers
2
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Co-authored papers
2
Michael J Gough
Earle A. Chiles Research Institute, Providence Cancer Institute
Co-authored papers
2
Nicholas K Foreman
Co-authored papers
2
Martin Sill
Co-authored papers
1
David Lagares
Fibrosis Research Center, Massachusetts General Hospital, Harvard Medical School
Co-authored papers
1
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Co-authored papers
1
Joseph A Califano
University of California
Co-authored papers
1
Casey S Greene
Dartmouth College Geisel School of Medicine, Princeton University, University of Colorado Anschutz Medical Campus, University of Pennsylvania Perelman School of Medicine
Co-authored papers
1
Brisa Pe??a
Cardiovascular Institute, University of Colorado Denver Anschutz Medical Campus
Co-authored papers
1
Martin D McCarter
University of Colorado School of Medicine
Co-authored papers
1
1 - 30